Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02025959 · ClinicalTrials.gov registry record · NA
Sleep for Inpatients: Empowering Staff to Act
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT02025959: Completed NA study, sponsored by University of Chicago.
NCT02025959 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02025959, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
Getting better sleep in the hospital is especially important due to a variety of adverse health effects that can potentially worsen patient recovery. To address these concerns and improve sleep in US hospitals, we aim to develop the SIESTA (Sleep for Inpatients: Empowering Staff to Act) program as an educational intervention designed to prepare hospital staff to assist patients in obtaining better sleep in hospitals and recognize the importance of screening for sleep disorders. The major educational goals of this proposal is to develop and pilot test an online educational program (SIESTA) which aims to train and motivate medical professionals to provide better sleep for hospitalized patients. We will utilize data from an ongoing sleep study, performed by the research team at the University of Chicago that looks at how adult patients are able to sleep while they are in the hospital, as a means of education for the participating medical staff.
Primary Outcome
We will assess if the SIESTA program translates into behavior change based on staff satisfaction, knowledge, behavior and qualitative analysis.
Interventions
- BEHAVIORAL Educating hospital staff on good sleep hygiene for patients and screening for sleep disorders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-08 |
| Est. Completion | 2022-08 |
| Phase | NA |
What the finished NCT02025959 record still lists
NCT02025959 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Educating hospital staff on good sleep hygiene for patients and screening for sleep disorders is the first listed.
NCT02025959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02025959 about?
NCT02025959 is a clinical study titled "Sleep for Inpatients: Empowering Staff to Act". Getting better sleep in the hospital is especially important due to a variety of adverse health effects that can potentially worsen patient recovery. To address these concerns and improve sleep in US hospitals, we aim to develop the SIESTA (Sleep for Inpatients: Empowering Staff to Act) program as ...
What is the current status of trial NCT02025959?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2013-08. Estimated completion is 2022-08.
What interventions are being tested in trial NCT02025959?
The interventions under investigation include: Educating hospital staff on good sleep hygiene for patients and screening for sleep disorders (BEHAVIORAL).
Who is sponsoring clinical trial NCT02025959?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02025959's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia